Pulmonary venous structural remodelling in a canine model of chronic atrial dilation due to mitral regurgitation

Canadian Journal of Cardiology

Volumn 24, Issue 4, 2008, Pages 305-308

  Sun, Qi ^a   Tang, Min ^b   Pu, Jielin ^a   Zhang, Shu ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Gap junction; Pulmonary vein; Remodelling

Indexed keywords

CONNEXIN 40; CONNEXIN 43; POLYCLONAL ANTIBODY; GAP JUNCTION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CHRONIC DISEASE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOG; FEMALE; GAP JUNCTION; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; IMMUNOHISTOCHEMISTRY; MALE; MITRAL VALVE REGURGITATION; NONHUMAN; PULMONARY VEIN; VASCULAR FIBROSIS; VEIN DIAMETER; ANIMAL; CARDIOMEGALY; CELL JUNCTION; CONFOCAL MICROSCOPY; DISEASE MODEL; FIBROSIS; FLUORESCENCE MICROSCOPY; HEART ATRIUM; HEART STROKE VOLUME; PATHOLOGY; PHYSIOLOGY; SUPRAVENTRICULAR PREMATURE BEAT;

ANIMALS; ATRIAL FIBRILLATION; ATRIAL PREMATURE COMPLEXES; CARDIOMEGALY; CHRONIC DISEASE; CONNEXIN 43; CONNEXINS; DISEASE MODELS, ANIMAL; DOGS; FEMALE; FIBROSIS; GAP JUNCTIONS; HEART ATRIA; MALE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MITRAL VALVE INSUFFICIENCY; PULMONARY VEINS; STROKE VOLUME;

EID: 42949118385     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(08)70181-8     Document Type: Article

References (24)

1. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population based cohort: The Framingham Heart Study. JAMA 1994;271:840-4.
2. Schoonderwoerd BA, Van Gelder IC, Van Veldhuisen DJ, Van den Berg MP, Crijns HJ. Electrical and structural remodeling: Role in the genesis and maintenance of atrial fibrillation. Prog Cardiovasc Dis 2005;48:153-68.
3. Kleber AG, Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev 2004;84:431-88.
4. Gros DB, Jongsma HJ. Connexins in mammalian heart function. Bioessays 1996;18:719-30.
5. Nattel S, Li D, Yue L. Basic mechanisms of atrial fibrillation - very new insights into very old ideas. Annu Rev Physiol 2000;62:51-77.
6. Davis LM, Kanter HL, Beyer EC, Saffitz JE. Distinct gap junction protein phenotypes in cardiac tissues with disparate conduction properties. J Am Coll Cardiol 1994;24:1124-32.
7. Verheule S, Wilson E, Everett T 4th, Shanbhag S, Golden C, Olgin J. Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilation due to mitral regurgitation. Circulation 2003;107:2615-22.
8. Rucker-Martin C, Milliez P, Tan S, et al. Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts. Cardiovasc Res 2006;72:69-79.
9. Takeuchi S, Akita T, Takagishi Y, et al. Disorganization of gap junction distribution in dilated atria of patients with chronic atrial fibrillation. Circ J 2006;70:575-82.
10. Neuberger HR, Schotten U, Verheule S, et al. Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat. Circulation 2005;111:30-7.
11. Ohara K, Miyauchi Y, Ohara T, et al. Downregulation of immunodetectable atrial connexin40 in a canine model of chronic left ventricular myocardial infarction: Implications to atrial fibrillation. J Cardiovasc Pharmacol Ther 2002;7:89-94.
12. Wilhelm M, Kirste W, Kuly S, et al. Atrial distribution of connexin 40 and 43 in patients with intermittent, persistent, and postoperative atrial fibrillation. Heart Lung Circ 2006;15:30-7.
13. Kumar NM, Gilula NB. The gap junction communication channel. Cell 1996;84:381-8.
14. Rohr S. Role of gap junctions in the propagation of the cardiac action potential. Cardiovasc Res 2004;62:309-22.
15. Dupont E, Ko Y, Rothery S, et al. The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation 2001;103:842-9.
16. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002;54:361-79.
17. Nao T, Ohkusa T, Hisamatsu Y, et al. Comparison of expression of connexin in right atrial myocardium in patients with chronic atrial fibrillation versus those in sinus rhythm. Am J Cardiol 2003;91:678-83.
18. Polontchouk L, Haefliger JA, Ebelt B, et al. Effects of chronic atrial brillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 2001;38:883-91.
19. van der Velden HM, Ausma J, Rook MB. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res 2000;46:476-86.
20. Guerra JM, Everett TH 4th, Lee KW, Wilson E, Olgin JE. Effects of the gap junction modifier rotigaptide (ZP123) on atrial conduction and vulnerability to atrial fibrillation. Circulation 2006;114:110-8.
21. Giepmans BN. Gap junctions and connexin-interacting proteins. Cardiovasc Res 2004;62:233-45.
22. Luo MH, Li YS, Yang KP. Fibrosis of collagen I and remodeling of connexin 43 in atrial myocardium of patients with atrial fibrillation. Cardiology 2006;107:248-53.
23. van der Velden HM, Jongsma HJ. Cardiac gap junctions and connexins: Their role in atrial fibrillation and potential as therapeutic targets. Cardiovasc Res 2002;54:270-9.
24. Qu Z, Karagueuzian HS, Garfinkel A, Weiss JN. Effects of Na(+) channel and cell coupling abnormalities on vulnerability to reentry: A simulation study. Am J Physiol Heart Circ Physiol 2004;286:H1310-21.